The board of Cerebral voted to replace co-founder Kyle Robertson, the Wall Street Journal reported May 17. Mr. Robertson later called the move illegal, according to the newspaper.
The U.S. Justice Department is investigating the company, which prescribes ADHD medications like Adderall virtually, over possible violations of the Controlled Substances Act. Cerebral recently paused the prescribing of most controlled substances and changed its online ads after critics said it could be fueling an addiction crisis.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.